1. Home
  2. BOSC vs CARM Comparison

BOSC vs CARM Comparison

Compare BOSC & CARM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOSC
  • CARM
  • Stock Information
  • Founded
  • BOSC 1990
  • CARM 2016
  • Country
  • BOSC Israel
  • CARM United States
  • Employees
  • BOSC N/A
  • CARM N/A
  • Industry
  • BOSC Computer Communications Equipment
  • CARM Biotechnology: Pharmaceutical Preparations
  • Sector
  • BOSC Telecommunications
  • CARM Health Care
  • Exchange
  • BOSC Nasdaq
  • CARM Nasdaq
  • Market Cap
  • BOSC N/A
  • CARM 7.7M
  • IPO Year
  • BOSC 1996
  • CARM N/A
  • Fundamental
  • Price
  • BOSC $4.52
  • CARM $0.19
  • Analyst Decision
  • BOSC Strong Buy
  • CARM Hold
  • Analyst Count
  • BOSC 1
  • CARM 5
  • Target Price
  • BOSC $5.00
  • CARM $0.90
  • AVG Volume (30 Days)
  • BOSC 428.9K
  • CARM 956.5K
  • Earning Date
  • BOSC 05-29-2025
  • CARM 05-13-2025
  • Dividend Yield
  • BOSC N/A
  • CARM N/A
  • EPS Growth
  • BOSC 35.10
  • CARM N/A
  • EPS
  • BOSC 0.49
  • CARM N/A
  • Revenue
  • BOSC $43,688,000.00
  • CARM $19,964,000.00
  • Revenue This Year
  • BOSC N/A
  • CARM N/A
  • Revenue Next Year
  • BOSC N/A
  • CARM N/A
  • P/E Ratio
  • BOSC $9.29
  • CARM N/A
  • Revenue Growth
  • BOSC 0.84
  • CARM 32.45
  • 52 Week Low
  • BOSC $2.50
  • CARM $0.14
  • 52 Week High
  • BOSC $5.50
  • CARM $1.90
  • Technical
  • Relative Strength Index (RSI)
  • BOSC 70.17
  • CARM 44.76
  • Support Level
  • BOSC $3.83
  • CARM $0.14
  • Resistance Level
  • BOSC $5.50
  • CARM $0.20
  • Average True Range (ATR)
  • BOSC 0.26
  • CARM 0.02
  • MACD
  • BOSC 0.06
  • CARM 0.00
  • Stochastic Oscillator
  • BOSC 47.59
  • CARM 71.47

About CARM Carisma Therapeutics Inc.

CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.

Share on Social Networks: